{
 "url": "https://etfiq.com/funds/sbio/holdings/",
 "section": "funds",
 "title": "SBIO Holdings: All 82 Positions (May 31, 2026) | ETFIQ",
 "description": "All 82 SBIO holdings with weights, as of May 31, 2026. The top 3 are ALKS 4.48%, KYMR 4.24% and CELC 3.92%. Download the full list as a CSV.",
 "as_of": "May 31, 2026",
 "ticker": "SBIO",
 "fund": "ALPS Medical Breakthroughs ETF",
 "fund_page": "https://etfiq.com/funds/sbio",
 "positions": 82,
 "positions_listed_on_page": 82,
 "lead": "SBIO held 82 positions as of May 31, 2026. Alkermes Plc is the largest at 4.48%; the top 10 are 34.8% of the fund.",
 "source": {
  "name": "Form N-PORT filed with the SEC",
  "url": "https://www.sec.gov/Archives/edgar/data/1414040/000104916926001879/primary_doc.xml",
  "document": "the fund’s SEC filing",
  "book_date": "2026-05-31",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "Alkermes Plc",
   "ticker": "ALKS",
   "weight_pct": 4.478,
   "page": "https://etfiq.com/holdings/alks/"
  },
  {
   "rank": 2,
   "holding": "Kymera Therapeutics Inc",
   "ticker": "KYMR",
   "weight_pct": 4.235,
   "page": "https://etfiq.com/holdings/kymr/"
  },
  {
   "rank": 3,
   "holding": "Celcuity Inc",
   "ticker": "CELC",
   "weight_pct": 3.917,
   "page": null
  },
  {
   "rank": 4,
   "holding": "Mirum Pharmaceuticals Inc",
   "ticker": "MIRM",
   "weight_pct": 3.902,
   "page": "https://etfiq.com/holdings/mirm/"
  },
  {
   "rank": 5,
   "holding": "Spyre Therapeutics Inc",
   "ticker": "SYRE",
   "weight_pct": 3.678,
   "page": "https://etfiq.com/holdings/syre/"
  },
  {
   "rank": 6,
   "holding": "Cg Oncology Inc",
   "ticker": "CGON",
   "weight_pct": 3.351,
   "page": "https://etfiq.com/holdings/cgon/"
  },
  {
   "rank": 7,
   "holding": "Apogee Therapeutics Inc",
   "ticker": "APGE",
   "weight_pct": 2.93,
   "page": null
  },
  {
   "rank": 8,
   "holding": "Xenon Pharmaceuticals Inc",
   "ticker": "XENE",
   "weight_pct": 2.901,
   "page": null
  },
  {
   "rank": 9,
   "holding": "Travere Therapeutics Inc",
   "ticker": "TVTX",
   "weight_pct": 2.772,
   "page": "https://etfiq.com/holdings/tvtx/"
  },
  {
   "rank": 10,
   "holding": "Dianthus Therapeutics Inc",
   "ticker": "DNTH",
   "weight_pct": 2.635,
   "page": "https://etfiq.com/holdings/dnth/"
  },
  {
   "rank": 11,
   "holding": "Newamsterdam Pharma Co Nv",
   "ticker": null,
   "weight_pct": 2.467,
   "page": null
  },
  {
   "rank": 12,
   "holding": "Viking Therapeutics Inc",
   "ticker": "VKTX",
   "weight_pct": 2.41,
   "page": "https://etfiq.com/holdings/vktx/"
  },
  {
   "rank": 13,
   "holding": "Crinetics Pharmaceuticals Inc",
   "ticker": "CRNX",
   "weight_pct": 2.371,
   "page": null
  },
  {
   "rank": 14,
   "holding": "Acadia Pharmaceuticals Inc",
   "ticker": "ACAD",
   "weight_pct": 2.353,
   "page": "https://etfiq.com/holdings/acad/"
  },
  {
   "rank": 15,
   "holding": "Edgewise Therapeutics Inc",
   "ticker": "EWTX",
   "weight_pct": 2.335,
   "page": null
  },
  {
   "rank": 16,
   "holding": "Denali Therapeutics Inc",
   "ticker": "DNLI",
   "weight_pct": 2.126,
   "page": "https://etfiq.com/holdings/dnli/"
  },
  {
   "rank": 17,
   "holding": "Oruka Therapeutics Inc",
   "ticker": "ORKA",
   "weight_pct": 1.805,
   "page": "https://etfiq.com/holdings/orka/"
  },
  {
   "rank": 18,
   "holding": "Structure Therapeutics Inc",
   "ticker": "GPCR",
   "weight_pct": 1.775,
   "page": null
  },
  {
   "rank": 19,
   "holding": "Disc Medicine Inc",
   "ticker": "IRON",
   "weight_pct": 1.691,
   "page": null
  },
  {
   "rank": 20,
   "holding": "Ideaya Biosciences Inc",
   "ticker": "IDYA",
   "weight_pct": 1.649,
   "page": "https://etfiq.com/holdings/idya/"
  },
  {
   "rank": 21,
   "holding": "Vera Therapeutics Inc",
   "ticker": "VERA",
   "weight_pct": 1.615,
   "page": null
  },
  {
   "rank": 22,
   "holding": "Tarsus Pharmaceuticals Inc",
   "ticker": "TARS",
   "weight_pct": 1.611,
   "page": "https://etfiq.com/holdings/tars/"
  },
  {
   "rank": 23,
   "holding": "Relay Therapeutics Inc",
   "ticker": "RLAY",
   "weight_pct": 1.6,
   "page": "https://etfiq.com/holdings/rlay/"
  },
  {
   "rank": 24,
   "holding": "Mineralys Therapeutics Inc",
   "ticker": "MLYS",
   "weight_pct": 1.588,
   "page": null
  },
  {
   "rank": 25,
   "holding": "Celldex Therapeutics Inc",
   "ticker": "CLDX",
   "weight_pct": 1.333,
   "page": "https://etfiq.com/holdings/cldx/"
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "Cash and other net assets",
   "weight_pct": -0.032
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/sbio/holdings/sbio-holdings.csv",
 "json_book": "https://etfiq.com/data/books/sbio.json",
 "markdown": "https://etfiq.com/funds/sbio/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of SBIO, data as of May 31, 2026. https://etfiq.com/funds/sbio/holdings/"
}